Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients

被引:108
作者
Lanchou, J [1 ]
Corbel, M
Tanguy, M
Germain, N
Boichot, E
Theret, N
Clement, B
Lagente, V
Malledant, Y
机构
[1] Univ Rennes, INSERM U456, Rennes, France
[2] CHU Rennes, Hop Pontchaillou, Serv Reanimat Chirurg, Rennes, France
关键词
matrix metalloproteinases; tissue inhibitor of matrix metalloproteinases; acute respiratory distress syndrome; acute lung injury;
D O I
10.1097/01.CCM.0000048626.02184.F8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Matrix metalloproteinases (MMPs) are known to be involved in degradation of extracellular matrix. We aimed to assess the role of MMPs and their natural inhibitors (TIMPs) in the genesis and the evolution of acute respiratory distress syndrome (ARDS). Design: Prospective, clinical study. Setting: Intensive care unit of a university hospital. Patients: Twenty-one patients were assigned to three different groups: Group 1 patients developed ARDS that rapidly resolved in <4 days; Group 2 patients developed ARDS lasting >8 days; Group 3 (control group) patients had clinical criteria for hospital-acquired pneumonia without ARDS. Intervention: Bronchoalveolar lavages were performed on day 0 of the onset of ARDS and on days 4, 8, and 12 for unresolving ARDS. For group 3, the bronchoalveolar lavages were performed on day 0 of the pneumonia. On these bronchoalveolar lavage fluids, we measured the amount of MMP-9 and -2 and their inhibitors TIMP-1 and -2. Measurements and Main Results: The amount of MMP-9 measured by enzyme-linked immunosorbent assay was significantly lower in the bronchoalveolar lavages from patients with ARDS (group 1 and group 2) compared with the control group (p < .01) throughout the study. The ratio MMP-9/TIMP-1 was also significantly smaller and was less than one in the two ARDS groups (p < .05) compared with the control group (group 3), where this ratio was greater than one. In the second bronchoalveolar lavages, this ratio was greater than one only in the ARDS group that rapidly resolved (group 1), whereas it stayed less than one when the ARDS was lasting (group 2). Concerning the quantity of MMP-2 and the ratio MMP-2/TIMP-2, there was no statistical difference between the three groups throughout the study. Using zymography, there was no significant difference in the amounts of active and latent MMP-9 between the three groups. Moreover, no significant difference in the quantity of latent and active MMP-2 in the three groups was noted. Conclusion: These results suggest that the MMP-9 level and MMP-9/TIMP-1 ratio play a role in the pathogenesis of ARDS and, namely, the imbalance between MMP-9 and TIMP-1 would participate in airway remodeling leading to either short- or long-course ARDS. The ratio MMP-9/TIMP-1 could be a predictive factor of the ARDS evolution.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [31] Expression of matrix metalloproteinases (MMP-2 and MMP-9) in vocal fold polyps
    Lesauskaite, Vaiva
    Uloza, Virgilijus
    Liutkevicius, Vykintas
    Pangonyte, Dalia
    MEDICINA-LITHUANIA, 2008, 44 (04): : 322 - 327
  • [32] Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder
    Bobinska, Kinga
    Szemraj, Janusz
    Czarny, Piotr
    Galecki, Piotr
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 205 : 119 - 129
  • [33] Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis
    Azevedo Martins, Jordana Maria
    Rabelo-Santos, Silvia Helena
    do Amaral Westin, Maria Cristina
    Zeferino, Luiz Carlos
    BMC CANCER, 2020, 20 (01)
  • [34] Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation
    Lee, Eugene S.
    Shen, Qiang
    Pitts, Robert L.
    Guo, Mingzhang
    Wu, Mack H.
    Sun, Sue C.
    Yuan, Sarah Y.
    JOURNAL OF VASCULAR SURGERY, 2011, 54 (02) : 454 - 459
  • [35] ASSESSMENT OF SERUM MMP-9, TIMP-1 LEVELS AND MMP-9/TIMP-1 RATIO IN MIGRAINE PATIENTS WITH AND WITHOUT AURA
    Karademir, Fazilet
    Ozturk, Musa
    Altunkaynak, Yavuz
    Doventas, Yasemin
    Mutluay, Belgin
    Koseahmet, Fulya Basoglu
    Baybas, Sevim
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (9-10): : 341 - 349
  • [36] Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer
    Huang, Xiwen
    Lan, Yongquan
    Li, En
    Li, Jiaquan
    Deng, Qiaoting
    Deng, Xunwei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (05)
  • [37] The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma
    Mashhadiabbas, Fatemeh
    Mahjour, Faranak
    Mahjour, Seyyed Babak
    Fereidooni, Forouzandeh
    Hosseini, Fatemeh Sadat
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2012, 114 (02): : 240 - 250
  • [38] Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients
    Diekmann, Ulf
    Zarbock, Ralf
    Hendig, Doris
    Szliska, Christiane
    Kleesiek, Knut
    Goetting, Christian
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (10): : 965 - 970
  • [39] Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle
    Schoser, BG
    Blottner, D
    NEUROREPORT, 1999, 10 (13) : 2795 - 2797
  • [40] Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients
    Ulf Diekmann
    Ralf Zarbock
    Doris Hendig
    Christiane Szliska
    Knut Kleesiek
    Christian Götting
    Journal of Molecular Medicine, 2009, 87 : 965 - 970